Inert-glass guarantees are not standard
Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease
oz.) Water/Aqua/Eau, Ethylhexyl Palmitate, Glycerin, Aleurites Moluccana Seed Oil, Polyacrylamide, Cetearyl Alcohol, C13-14 Isoparaffin, Polysorbate 60, Glyceryl Stearate, PEG-100 Stearate, Dimethyl MEA, Tetrahexyldecyl Ascorbate, Tyrosine, Hydrolyzed Wheat Protein, Tocopheryl Acetate, Hydrolyzed Wheat Starch, Citric Acid, PEG/PPG-18/18 Dimethicone, Dimethicone, Caprylyl Glycol, Laureth-7, Hexylene Glycol, Phenoxyethanol, Fragrance/Parfum, Citronellol, Geraniol, Hydroxycitronellal, Butylphenyl Methylpropional, Benzyl Benzoate, Eugenol For the latest information, it is recommended to review the ingredient list printed on the packaging of the product prior to usage or consumption
It is not approved for human or animal use and should only be handled by qualified researchers in appropriate laboratory settings
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
